19-54274829-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001080978.4(LILRB2):ā€‹c.1648G>Cā€‹(p.Ala550Pro) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000435 in 1,610,920 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.0000067 ( 0 hom., cov: 30)
Exomes š‘“: 0.0000041 ( 0 hom. )

Consequence

LILRB2
NM_001080978.4 missense, splice_region

Scores

3
13
Splicing: ADA: 0.2057
2

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.751
Variant links:
Genes affected
LILRB2 (HGNC:6606): (leukocyte immunoglobulin like receptor B2) This gene is a member of the leukocyte immunoglobulin-like receptor (LIR) family, which is found in a gene cluster at chromosomal region 19q13.4. The encoded protein belongs to the subfamily B class of LIR receptors which contain two or four extracellular immunoglobulin domains, a transmembrane domain, and two to four cytoplasmic immunoreceptor tyrosine-based inhibitory motifs (ITIMs). The receptor is expressed on immune cells where it binds to MHC class I molecules on antigen-presenting cells and transduces a negative signal that inhibits stimulation of an immune response. It is thought to control inflammatory responses and cytotoxicity to help focus the immune response and limit autoreactivity. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.1375379).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
LILRB2NM_001080978.4 linkuse as main transcriptc.1648G>C p.Ala550Pro missense_variant, splice_region_variant 14/14 ENST00000314446.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
LILRB2ENST00000314446.10 linkuse as main transcriptc.1648G>C p.Ala550Pro missense_variant, splice_region_variant 14/141 NM_001080978.4 A2Q8N423-2

Frequencies

GnomAD3 genomes
AF:
0.00000670
AC:
1
AN:
149190
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000202
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000159
AC:
4
AN:
251216
Hom.:
0
AF XY:
0.0000147
AC XY:
2
AN XY:
135852
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000410
AC:
6
AN:
1461730
Hom.:
0
Cov.:
31
AF XY:
0.00000275
AC XY:
2
AN XY:
727174
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000224
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.0000756
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.00000670
AC:
1
AN:
149190
Hom.:
0
Cov.:
30
AF XY:
0.0000138
AC XY:
1
AN XY:
72676
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000202
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.00000378
ExAC
AF:
0.00000824
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 19, 2024The c.1651G>C (p.A551P) alteration is located in exon 14 (coding exon 13) of the LILRB2 gene. This alteration results from a G to C substitution at nucleotide position 1651, causing the alanine (A) at amino acid position 551 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.34
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
21
DANN
Uncertain
0.99
Eigen
Benign
-0.57
Eigen_PC
Benign
-0.67
FATHMM_MKL
Benign
0.040
N
LIST_S2
Benign
0.63
.;.;T;.
M_CAP
Benign
0.0025
T
MetaRNN
Benign
0.14
T;T;T;T
MetaSVM
Benign
-0.98
T
MutationTaster
Benign
1.0
D;N;N;N;N
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-2.3
N;N;N;N
REVEL
Benign
0.072
Sift
Uncertain
0.0020
D;D;D;D
Sift4G
Uncertain
0.0090
D;D;D;D
Vest4
0.14
MutPred
0.23
.;.;.;Gain of glycosylation at A551 (P = 0.1056);
MVP
0.37
MPC
0.33
ClinPred
0.43
T
GERP RS
1.3
gMVP
0.10

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.21
dbscSNV1_RF
Benign
0.64
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs750260466; hg19: chr19-54778683; API